RobertLevinMD

PubMed

• Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer.
  Stephenson, C. M.,Levin, R. D.,Spector, T.,Lis, C. G.> ;Cancer Chemother. Pharmacol.. 2013 Jul
• Cost differences among treatment options for patients with refractory myeloma previously treated with high-dose chemotherapy and autologous stem-cell transplantation: ...
  Blank PR, Levin R, Pestalozzi BC, Szucs TD> ;J. Clin. Oncol.. 2011-05-20
• Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms.
  Hrushesky WJM, Grutsch J, Wood P, Yang X, Oh E, Ansell C, Kidder S, Ferrans C, Quiton DFT, Reynolds J, Du-Quiton J, Levin R, Lis C, Braun D> ;Integr Cancer Ther. 2009-12-01
• Phase 1 trial of high-dose intravenous vitamin C treatment for patients with cancer.
  Stephenson, C.M., Levin, R.D., Lis, C.G.> ;J Am Osteopath Assoc. 2007 Jun
• A prospective study evaluating the relationship between fatigue and patient satisfaction in advanced cancer.
  Levin RD, Daehler M, Lis CG, Gupta D, Wodek T, Grutsch JF, Granick J, Williams S, Citrin DL, Neelam R> ;J. Clin. Oncol.. 2006-06-20
• Identifying optimal cutpoints for quality of life function in patients with advanced cancer.
  Grutsch JF, Lis CG, Granick J, Levin RD, Williams S, Wodek T, Gupta D> ;J. Clin. Oncol.. 2005-06-01
• Quality of life outcomes of breast cancer in an integrative treatment setting: The Cancer Treatment Centers of America experience.
  Granick J, Lis CG, Levin R, Neelam R, Brikshavana D, Gupta D> ;J. Clin. Oncol.. 2004-07-15
• Quality of life assessment as a prognostic tool in breast cancer.
  Neelam R, Gupta D, Brikshavana D, Levin RD, Granick J, Grutsch J, Wodek T, Lis CG> ;J. Clin. Oncol.. 2004-07-15
• Quality of life outcomes of advanced colorectal cancer in an integrative treatment setting: The Cancer Treatment Centers of America experience.
  Lis CG, Gupta D, Levin RD, Granick J, Neelam R, Hoffman S, Vashi PG, Lammersfeld CA> ;J. Clin. Oncol.. 2004-07-15
• The relationship between quality of life and nutritional status in advanced colorectal cancer.
  Williams S, Gupta D, Levin RD, Lammersfeld CA, Hoffman S, Vashi PG, Grutsch JF, Wodek T, Lis CG> ;J. Clin. Oncol.. 2004-07-15
• Quality of life assessment in clinical oncology: Implications for prognosis in advanced colorectal cancer.
  Levin RD, Gupta D, Hoffman S, Granick J, Neelam R, Vashi PG, Daehler M, Wodek T, Quinn K, Lis CG> ;J. Clin. Oncol.. 2004-07-15
• Evaluation of the Functional Assessment of Cancer Therapy-General Questionnaire (FACT-G) in a South American Spanish speaking population.
  Dapueto JJ, Francolino C, Gotta I, Levin R, Alonso I, Barrios E, Afonzo Y, Cambiasso S> ;Psychooncology. 2001-01-01
• "Salvage" therapy?
  Levin R> ;J. Clin. Oncol.. 1994-09-01
• Subpopulation of human helper and suppressor T lymphocytes.
  Venkataraman M, Levin RD, Westerman MP> ;Hum. Immunol.. 1983-07-01
• Suppression of B-lymphocyte function by T-lymphocytes in patients with advanced lung cancer.
  Venkataraman, M., Rao, D. S., Levin, R. D., Westerman, M. P.> ;J Natl Cancer Inst. 1985 Jan
• Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer.
  Cole, D. J., Sanda, M. G., Yang, J. C., Schwartzentruber, D. J., Weber, J., Ettinghausen, S. E., Pockaj, B. A., Kim, H. I., Levin, R. D., Pogrebniak, H. W.> ;J Natl Cancer Inst. 1994 Jan 5
• Phase I clinical trial with floxuridine and high-dose continuous infusion of leucovorin calcium.
  Levin, R. D., Gordon, J. H., Simonich, W., Mellijor, A., Sanchez, R., Williams, R. M.> ;J Clin Oncol. 1991 Jan
• Fluorodeoxyuridine with continuous leucovorin infusion. A phase II clinical trial in patients with metastatic colorectal cancer.
  Levin, R. D., Gordon, J. H.> ;Cancer. 1993 Nov 15
• 91 citations
  Circadian function in patients with advanced non-small-cell lung cancer.
  Robert D. Levin, M. Daehler, James F. Grutsch, Jovelyn Du Quiton, Christopher G. Lis, Caryn E. Peterson, Digant Gupta, Kathleen V Watson, D Layer, S Huff-Adams, B Desa...> ;British Journal of Cancer. 2005 Nov 28
• The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer.
  Grutsch, J. F., Ferrans, C., Wood, P. A., Du-Quiton, J., Quiton, D. F., Reynolds, J. L., Ansell, C. M., Oh, E. Y., Daehler, M. A., Levin, R. D., Braun, D. P., Gupta, D...> ;BMC Cancer. 2011
• Validation of actigraphy to assess circadian organization and sleep quality in patients with advanced lung cancer.
  Grutsch, J. F., Wood, P. A., Du-Quiton, J., Reynolds, J. L., Lis, C. G., Levin, R. D., Ann Daehler, M., Gupta, D., Quiton, D. F., Hrushesky, W. J.> ;J Circadian Rhythms. 2011
• 3 citations
  Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia
  Robert D. Levin, MaryAnn Daehler, James Grutsch, John L Hall, Digant Gupta, Christopher G. Lis> ;BMC Cancer. 2010 Oct 19
• Actigraphic assessment of daily sleep-activity pattern abnormalities reflects self-assessed depression and anxiety in outpatients with advanced non-small cell lung can...
  Du-Quiton, J., Wood, P. A., Burch, J. B., Grutsch, J. F., Gupta, D., Tyer, K., Lis, C. G., Levin, R. D., Quiton, D. F., Reynolds, J. L., Hrushesky, W. J.> ;Psychooncology. 2010 Feb 01
• Join now to see all